Morlaix, Brittany (France), April 9th 2020 – Hemarina, the Breton biotech company, acknowledged the ANSM decision to suspend Monaco trial
Morlaix, Brittany (France) – Sept, 9, 2020 – Hemarina, a biotechnology company based in Brittany, announced today the publication of
on France Inter https://www.franceinter.fr/emissions/chroniques-littorales/chroniques-littorales-10-septembre-2019
Read the full article by Yassine Khelfa :https://fr.blastingnews.com/societe/2020/10/hemarina-la-societe-bretonne-qui-pourrait-redonner-un-souffle-nouveau-face-au-covid-19-003216222.html
https://www.letelegramme.fr/finistere/morlaix/covid-19-ou-en-est-le-respirateur-moleculaire-d-hemarina-17-11-2020-12658210.php
Morlaix, Brest (France), 26 November 2020 – Brest University Hospital and Hemarina, a biotech company based in Brittany, announced today
Hemarina announced on September 9 the publication of a paper in Scientific Reports demonstrating the anti-inflammatory and antibacterial properties of
Have a look at the entire TV report broadcasted on January 23rd 2021:https://www.daserste.de/information/wissen-kultur/w-wie-wissen/videos/wattwurmblut-video-100.html
